RED BLOOD CELLS

Red Blood Cells Adverse Events Reported to the FDA Over Time

How are Red Blood Cells adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Red Blood Cells, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Red Blood Cells is flagged as the suspect drug causing the adverse event.

Most Common Red Blood Cells Adverse Events Reported to the FDA

What are the most common Red Blood Cells adverse events reported to the FDA?

Transfusion-related Acute Lung Inju...	49 (4.84%)
Pulmonary Oedema	22 (2.17%)
Transfusion Reaction	22 (2.17%)
Hypotension	21 (2.08%)
Transmission Of An Infectious Agent...	16 (1.58%)
Dyspnoea	15 (1.48%)
Pyrexia	15 (1.48%)
Hepatitis C	14 (1.38%)
Hepatitis C Positive	14 (1.38%)
Hypoxia	14 (1.38%)
Lung Infiltration	14 (1.38%)
	Show More
Aspartate Aminotransferase Increase...	12 (1.19%)
Haemolysis	12 (1.19%)
Tachycardia	12 (1.19%)
Alanine Aminotransferase Increased	11 (1.09%)
Hepatitis B	11 (1.09%)
Medication Error	11 (1.09%)
Hepatitis C Antibody Positive	10 (.99%)
Anaemia	9 (.89%)
Anti-hbs Antibody Positive	9 (.89%)
Chills	9 (.89%)
Shock	9 (.89%)
Blood Alkaline Phosphatase Increase...	8 (.79%)
Hepatitis B Surface Antigen Positiv...	8 (.79%)
Multi-organ Failure	8 (.79%)
Nausea	8 (.79%)
Thrombocytopenia	8 (.79%)
Vomiting	8 (.79%)
Anti-hbc Antibody Positive	7 (.69%)
Haemoglobin Decreased	7 (.69%)
Haemolytic Anaemia	7 (.69%)
Renal Failure	7 (.69%)
Renal Failure Acute	7 (.69%)
Acute Respiratory Failure	6 (.59%)
Heart Rate Increased	6 (.59%)
Laboratory Test Abnormal	6 (.59%)
Respiratory Distress	6 (.59%)
Respiratory Rate Increased	6 (.59%)
Wheezing	6 (.59%)
Blood Bilirubin Increased	5 (.49%)
Blood Pressure Decreased	5 (.49%)
Bronchospasm	5 (.49%)
Haemoglobinuria	5 (.49%)
Hepatic Enzyme Increased	5 (.49%)
Hepatitis	5 (.49%)
Hepatitis B Antibody Positive	5 (.49%)
Hypertension	5 (.49%)
Infusion Related Reaction	5 (.49%)
Liver Disorder	5 (.49%)
Oxygen Saturation Decreased	5 (.49%)
Post Procedural Haemorrhage	5 (.49%)
Product Quality Issue	5 (.49%)
Acute Respiratory Distress Syndrome	4 (.4%)
Anti-erythrocyte Antibody Positive	4 (.4%)
Blood Lactate Dehydrogenase Increas...	4 (.4%)
Body Temperature Increased	4 (.4%)
Cardio-respiratory Arrest	4 (.4%)
Chest Pain	4 (.4%)
Chromaturia	4 (.4%)
Circulatory Collapse	4 (.4%)
Condition Aggravated	4 (.4%)
Creutzfeldt-jakob Disease	4 (.4%)
Febrile Neutropenia	4 (.4%)
Gastrointestinal Haemorrhage	4 (.4%)
General Physical Health Deteriorati...	4 (.4%)
Haematocrit Decreased	4 (.4%)
Haemorrhage	4 (.4%)
Oliguria	4 (.4%)
Pneumonia	4 (.4%)
Post Procedural Complication	4 (.4%)
Toxic Epidermal Necrolysis	4 (.4%)
Tremor	4 (.4%)
Anti-hbc Igm Antibody Positive	3 (.3%)
Anxiety	3 (.3%)
Atelectasis	3 (.3%)
Autoimmune Disorder	3 (.3%)
Blood Creatinine Increased	3 (.3%)
Brain Abscess	3 (.3%)
Cardiogenic Shock	3 (.3%)
Cardiomegaly	3 (.3%)
Crepitations	3 (.3%)
Cyanosis	3 (.3%)
Disease Progression	3 (.3%)
Disseminated Intravascular Coagulat...	3 (.3%)
Drug Dispensing Error	3 (.3%)
Fatigue	3 (.3%)
Hepatitis A Antibody Positive	3 (.3%)
Hepatitis B Positive	3 (.3%)
Htlv-1 Test Positive	3 (.3%)
Hyperbilirubinaemia	3 (.3%)
Hyperhidrosis	3 (.3%)
Hyperkalaemia	3 (.3%)
Incorrect Product Storage	3 (.3%)
Intravascular Haemolysis	3 (.3%)
Leukocytosis	3 (.3%)
Loss Of Consciousness	3 (.3%)
Myocardial Infarction	3 (.3%)
Myocardial Ischaemia	3 (.3%)
Pancytopenia	3 (.3%)
Pleural Effusion	3 (.3%)
Procedural Complication	3 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Red Blood Cells, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Red Blood Cells is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Red Blood Cells

What are the most common Red Blood Cells adverse events reported to the FDA?

Procedural And Device Related Injur...	89 (8.79%)
Microbiology And Serology	73 (7.21%)
Respiratory	53 (5.24%)
Lower Respiratory Tract Disorders	48 (4.74%)
Hepatobiliary	38 (3.75%)
Decreased And Nonspecific Blood Pre...	34 (3.36%)
Viral Infectious	32 (3.16%)
Hematology Investigations	30 (2.96%)
Cardiac Arrhythmias	25 (2.47%)
Gastrointestinal Signs	23 (2.27%)
Hemolyses And Related Conditions	23 (2.27%)
	Show More
Medication Errors	22 (2.17%)
Ancillary Infectious Topics	21 (2.08%)
Renal Disorders	21 (2.08%)
Cardiac And Vascular Investigations	18 (1.78%)
Hepatic And Hepatobiliary	18 (1.78%)
Body Temperature Conditions	17 (1.68%)
Infections - Pathogen Unspecified	17 (1.68%)
Epidermal And Dermal Conditions	16 (1.58%)
Anemias Nonhemolytic And Marrow Dep...	15 (1.48%)
Enzyme	14 (1.38%)
Physical Examination Topics	13 (1.28%)
Bronchial Disorders	11 (1.09%)
Metabolic, Nutritional And Blood Ga...	11 (1.09%)
Neurological	11 (1.09%)
Product Quality Issues	11 (1.09%)
White Blood Cell	11 (1.09%)
Urinary Tract Signs	10 (.99%)
Coronary Artery	9 (.89%)
Electrolyte And Fluid Balance Condi...	9 (.89%)
Heart Failures	8 (.79%)
Immunology And Allergy	8 (.79%)
Platelet	8 (.79%)
Water, Electrolyte And Mineral	8 (.79%)
Renal And Urinary Tract Investigati...	7 (.69%)
Administration Site Reactions	6 (.59%)
Cardiac Disorder Signs	6 (.59%)
Coagulopathies And Bleeding Diathes...	6 (.59%)
Investigations, Imaging And Histopa...	6 (.59%)
Leukemias	6 (.59%)
Gastrointestinal Hemorrhages	5 (.49%)
Protein And Chemistry Analyses	5 (.49%)
Vascular Hypertensive	5 (.49%)
Allergic Conditions	4 (.4%)
Anxiety Disorders	4 (.4%)
Fungal Infectious	4 (.4%)
Gastrointestinal Vascular Condition...	4 (.4%)
Hematological And Lymphoid Tissue T...	4 (.4%)
Movement Disorders	4 (.4%)
Skin Appendage Conditions	4 (.4%)
Therapeutic And Nontherapeutic Effe...	4 (.4%)
Vascular Hemorrhagic	4 (.4%)
Angiedema And Urticaria	3 (.3%)
Autoimmune	3 (.3%)
Cardiac Valve	3 (.3%)
Encephalopathies	3 (.3%)
Gastrointestinal Motility And Defec...	3 (.3%)
Injuries	3 (.3%)
Maternal Complications Of Labour An...	3 (.3%)
Myocardial	3 (.3%)
Ocular Infections, Irritations And ...	3 (.3%)
Peripheral Neuropathies	3 (.3%)
Pleural	3 (.3%)
Psychiatric	3 (.3%)
Pulmonary Vascular	3 (.3%)
Therapeutic Procedures And Supporti...	3 (.3%)
Vascular	3 (.3%)
Acid-base	2 (.2%)
Bone, Calcium, Magnesium And Phosph...	2 (.2%)
Chemical Injury And Poisoning	2 (.2%)
Depressed Mood Disorders	2 (.2%)
Fatal Outcomes	2 (.2%)
Gastrointestinal Inflammatory Condi...	2 (.2%)
Hematological	2 (.2%)
Hematopoietic Neoplasms	2 (.2%)
Immune	2 (.2%)
Immunodeficiency Syndromes	2 (.2%)
Neonatal Respiratory	2 (.2%)
Obstetric And Gynecological Therape...	2 (.2%)
Oral Soft Tissue Conditions	2 (.2%)
Plasma Cell Neoplasms	2 (.2%)
Protozoal Infectious	2 (.2%)
Aneurysms And Artery Dissections	1 (.1%)
Appetite And General Nutritional	1 (.1%)
Bacterial Infectious	1 (.1%)
Breast	1 (.1%)
Central Nervous System Infections A...	1 (.1%)
Central Nervous System Vascular	1 (.1%)
Deliria	1 (.1%)
Dental And Gingival Conditions	1 (.1%)
Glucose Metabolism Disorders	1 (.1%)
Iron And Trace Metal Metabolism	1 (.1%)
Joint	1 (.1%)
Lipid Analyses	1 (.1%)
Muscle	1 (.1%)
Musculoskeletal And Connective Tiss...	1 (.1%)
Neonatal And Perinatal Conditions	1 (.1%)
Neurological, Special Senses And Ps...	1 (.1%)
Ocular Neuromuscular	1 (.1%)
Peritoneal And Retroperitoneal Cond...	1 (.1%)
Red Blood Cell	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Red Blood Cells, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Red Blood Cells is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.